Home > Boards > US Listed > Medical - Drugs > Allergan (AGN)

(From AGN’s PR)—1Q19 worldwide Botox sales=$868.4M, +6% YoY

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 720
Posts 108,437
Boards Moderated 22
Alias Born 09/05/02
160x600 placeholder
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion--3rd Update Dow Jones News - 6/25/2019 8:05:00 AM
Global Stocks Waver as Gold and Bitcoin Soar Dow Jones News - 6/25/2019 7:56:00 AM
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion--2nd Update Dow Jones News - 6/25/2019 7:34:00 AM
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion--Update Dow Jones News - 6/25/2019 7:02:00 AM
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion Dow Jones News - 6/25/2019 6:56:00 AM
AbbVie to Acquire Allergan in Transformative Move for Both Companies PR Newswire (US) - 6/25/2019 6:42:00 AM
Allergan Receives FDA Clearance For CoolTone™ Device PR Newswire (US) - 6/24/2019 7:30:00 AM
FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity PR Newswire (US) - 6/21/2019 7:30:00 AM
Ironwood & Allergan Report Positive Topline Data from Phase IIIb Trial of LINZESS® (linaclotide) in Adults with Irritable Bo... Business Wire - 6/18/2019 4:05:00 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/17/2019 5:02:19 PM
FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab) PR Newswire (US) - 6/13/2019 7:13:00 PM
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar... PR Newswire (US) - 5/28/2019 7:30:00 AM
Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference PR Newswire (US) - 5/24/2019 4:05:00 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/23/2019 4:18:09 PM
Allergan to Present at the Jefferies 2019 Healthcare Conference PR Newswire (US) - 5/23/2019 7:30:00 AM
Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis PR Newswire (US) - 5/17/2019 7:30:00 AM
Allergan to Present at the Bernstein Strategic Decisions Conference PR Newswire (US) - 5/16/2019 7:30:00 AM
Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighti... PR Newswire (US) - 5/15/2019 7:30:00 AM
PatientFi® Announces Study Partnership with Allergan Business Wire - 5/15/2019 6:00:00 AM
Allergan to Present at the Bank of America Merrill Lynch 2019 Health Care Conference PR Newswire (US) - 5/9/2019 7:30:00 AM
Takeda Sells Eye Drug to Novartis -- WSJ Dow Jones News - 5/9/2019 3:02:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 5:29:05 PM
Allergan Reports First Quarter 2019 Financial Results PR Newswire (US) - 5/7/2019 7:00:00 AM
Medicines360 and Allergan Present Six-Year Clinical Data from Largest Ongoing Phase 3 Study of an Intrauterine System in the ... PR Newswire (US) - 5/6/2019 8:50:00 AM
Allergan Declares Second Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share PR Newswire (US) - 5/3/2019 7:45:00 AM
DewDiligence Member Level  Tuesday, 05/07/19 10:45:24 AM
Re: DewDiligence post# 180
Post # of 189 
(From AGN’s PR)—1Q19 worldwide Botox sales=$868.4M, +6% YoY (-8% QoQ*):

• US therapeutic: $397.6M (+6 YoY, -8% QoQ*)
• US cosmetic: $229.5M (+17% YoY, -11% QoQ*)
--
Total US sales: $627.1M (63% therapeutic, 37% cosmetic)


• Ex-US therapeutic: $93.9 (+7% YoY, -3% QoQ*)
• Ex-US cosmetic: $147.4M (+9% YoY, -7% QoQ*)
--
Total ex-US sales = $241.3M (39% therapeutic, 61% cosmetic)


*The 1Q19 QoQ decline relative to 4Q18 was expected; Botox is seasonally stronger in the second and fourth quarters of the calendar year.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist